Market Place
Sourcing Support
Myriad Genetics To Unveil Q1 2026 Financial Results On May 5
28 Apr 2026 //
GLOBENEWSWIRE
Myriad Genetics Expands Mychoice Test Access To Prostate Cancer
14 Apr 2026 //
GLOBENEWSWIRE
Myriad Genetics Underscores Cancer Care at SGO Annual Meeting
09 Apr 2026 //
GLOBENEWSWIRE
Myriad Launches Precise MRD With Community Oncologists
02 Mar 2026 //
GLOBENEWSWIRE
Myriad`s Tests Show Clinical Impact At ASCO-GU 2026
24 Feb 2026 //
GLOBENEWSWIRE
Myriad Genetics To Release Fourth Quarter And Full Year 2025
16 Feb 2026 //
GLOBENEWSWIRE
Myriad Genetics Releases 2025 Results and 2026 Guidance
12 Jan 2026 //
GLOBENEWSWIRE
Myriad Genetics To Present At J.P. Morgan Healthcare Conference
05 Jan 2026 //
GLOBENEWSWIRE
Myriad Genetics Presents 8 MRD Abstracts at SABCS 2025
09 Dec 2025 //
GLOBENEWSWIRE
Myriad Genetics Reaffirms 2025 Financial Outlook After Strong Q3
03 Nov 2025 //
GLOBENEWSWIRE
Myriad Genetics Raises 2025 Revenue Guidance Post Strong
05 Aug 2025 //
GLOBENEWSWIRE
Myriad Genetics Sells EndoPredict Business To Eurobio Scientific
01 Aug 2024 //
GLOBENEWSWIRE
Myriad Genetics Appoints Jennifer Fox as Chief Legal Officer
31 Jul 2024 //
GLOBENEWSWIRE
X4 Pharmaceuticals To Report Q2 2024 Results On August 8
30 Jul 2024 //
GLOBENEWSWIRE
Myriad Genetics Survey Reveals Breast Density Knowledge Gaps
17 Jul 2024 //
GLOBENEWSWIRE
Myriad And Personalis Cross-License MRD IP To Broaden Patient Access
11 Jul 2024 //
GLOBENEWSWIRE
Myriad Genetics Gets Second Patent For Molecular Residual Disease
09 Jul 2024 //
GLOBENEWSWIRE
Myriad Genetics Earns 2024 Great Place To Work® Certification
02 Jul 2024 //
GLOBENEWSWIRE
Survey Suggests Increased Focus On Mental Health Before Election
24 Jun 2024 //
GLOBENEWSWIRE
Myriad`s Prolaris Predicts Prostate Cancer Hormone Therapy Benefit
16 May 2024 //
GLOBENEWSWIRE
NICE backs wider tumour profiling use in early breast cancer
10 May 2024 //
PHARMAPHORUM
Nearly Half of Americans Lost Time Due to Poor Mental Health
17 Apr 2024 //
GLOBENEWSWIRE
Myriad Genetics Hires Five Senior Leaders to Advance Commercial Growth Plans
19 Dec 2022 //
GLOBENEWSWIRE
Myriad Genetics Patient Outcomes Study Shows to More Accurate Breast Cancer
08 Dec 2022 //
GLOBENEWSWIRE
Myriad to Present Data Showcasing Advancements in Breast Cancer Risk Assessment
29 Nov 2022 //
GLOBENEWSWIRE
Myriad Genetics Focuses on Expanding Access, Collaboration in Genetic Testing
14 Nov 2022 //
GLOBENEWSWIRE
Myriad Genetics Announces UroSuite™, an Industry-First Suite of Genetic Tests
10 Nov 2022 //
GLOBENEWSWIRE
New Study Published in JCO Precision Oncology Features Data Validating
03 Nov 2022 //
GLOBENEWSWIRE
Myriad Genetics Expands Consumer Access to Genetic Testing with Acquisition
01 Nov 2022 //
BIOSPACE
Myriad Genetics Elects of Paul M. Bisaro as New Board Member
31 Oct 2022 //
GLOBENEWSWIRE
Learn Look Locate Partners with Myriad Genetics, in Educational Campaign
13 Oct 2022 //
PRNEWSWIRE
New Study Published in Clinical Cancer Research Journal Highlights Use
31 Aug 2022 //
GLOBENEWSWIRE
Myriad Receives Expanded Coverage in Japan for Use of BRACAnalysis Diagnostic
25 Aug 2022 //
GLOBENEWSWIRE
Myriad Partners with Institut für Hämopathologie Hamburg and Centre Georges
16 Aug 2022 //
GLOBENEWSWIRE
Myriad Genetics to Release 2022 Second-Quarter Financial Results on Aug. 4, 2022
28 Jul 2022 //
GLOBENEWSWIRE
Myriad Genetics to Share Update on Growth Plans at Investor Day
19 Jul 2022 //
GLOBENEWSWIRE
Access to Myriad Genetics` GeneSight Test Improves Depression Remission Rates
12 Jul 2022 //
GLOBENEWSWIRE
Myriad Genetics Issues Inaugural Environmental, Social and Governance Report
28 Jun 2022 //
GLOBENEWSWIRE
Myriad Genetics Teams Up with Epic to Make Genetic Testing Accessible
23 Jun 2022 //
GLOBENEWSWIRE
Myriad Genetics CEO Paul Diaz to Speak at Goldman Sachs Healthcare Conference
09 Jun 2022 //
GLOBENEWSWIRE
Myriad Genetics Showcases Advancements in Precision Medicine with Oncology
26 May 2022 //
GLOBENEWSWIRE
Myriad Genetics Reports First Quarter Revenue and Reiterates Guidance for 2022
05 May 2022 //
GLOBENEWSWIRE
Myriad Genetics Expands Partnership with Intermountain Precision Genomics
03 May 2022 //
GLOBENEWSWIRE
Myriad Genetics to Release First-Quarter 2022 Financial Results on May 5, 2022
28 Apr 2022 //
GLOBENEWSWIRE
Myriad Genetics Advances Precision Oncology with New Precise Solutions
14 Mar 2022 //
GLOBENEWSWIRE
FDA Approves Myriad`s BRACAnalysis CDx as Companion Diagnostic for Lynparza
11 Mar 2022 //
GLOBENEWSWIRE
Myriad Genetics CEO Paul Diaz to Speak at Annual Cowen Health Care Conference
02 Mar 2022 //
GLOBENEWSWIRE
Myriad Genetics Reports Q4 2021 Results, Provides Updates
24 Feb 2022 //
GLOBENEWSWIRE
Myriad Genetics to Present at Two Upcoming Healthcare Conferences
14 Feb 2022 //
GLOBENEWSWIRE
